Skip to main content
Christopher Hourigan, MD, Oncology, Washington, DC, Sibley Memorial Hospital

ChristopherSimonHouriganMD

Oncology • Washington, DC

Physician

Join to view full profile

Dr. Hourigan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hourigan's full profile

Already have an account?

  • Office

    5255 Loughboro Road NW, Johns Hopkins Kimmel Cancer Center
    5255 Loughboro Rd NW
    Washington, DC 20016
    Phone+1 202-660-6500
  • Is this information wrong?

Summary

  • Christopher S. Hourigan DM DPhil FACP FRCP is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and a part-time associate professor of oncology at Johns Hopkins University School of Medicine. Dr. Hourigan is board certified in internal medicine, hematology and medical oncology by the American Board of Internal Medicine.

    Dr. Hourigan has expertise in myeloid malignancies. He sees adult patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) for second opinions at Sibley Memorial Hospital where he is also a member of the Hematological Malignancies Inpatient Service.

    Dr. Hourigan received his Doctor of Medicine and PhD from Oxford University, and completed postgraduate clinical training in London and Baltimore. He has particular interest in approaches to predict development or recurrence of myeloid malignancy.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2012 - 2012
  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2009 - 2011
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2007 - 2009
  • Oxford University Medical School
    Oxford University Medical SchoolClass of 2006
  • Oxford University Medical School
    Oxford University Medical SchoolD.Phil., Human Immunology

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2010 - 2024
  • DC State Medical License
    DC State Medical License 2018 - 2022
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Fellow, Royal College of Physicians 2018
  • Alpha Omega Alpha Johns Hopkins Chapter

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Novel Proteomic Profiling of the Bone Marrow Microenvironment Reveals Elevated Levels of the Chemokine CCL23 Isoforms in Acute Myeloid Leukemia
    Christopher S. Hourigan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • DNA-Sequencing Testing Used to Detect Residual AML Prior to Transplant
    DNA-Sequencing Testing Used to Detect Residual AML Prior to TransplantApril 10th, 2023
  • Blood Test May Identify Patients with AML at Greater Risk of Relapse After Bone Marrow Transplant
    Blood Test May Identify Patients with AML at Greater Risk of Relapse After Bone Marrow TransplantMarch 9th, 2023
  • Research Shows the Benefits of Screening AML Patients in Remission for Residual Disease Before Bone Marrow Transplant
    Research Shows the Benefits of Screening AML Patients in Remission for Residual Disease Before Bone Marrow TransplantMarch 7th, 2023
  • Join now to see all

Professional Memberships

Hospital Affiliations

Dr. Christopher Hourigan, Dr. Christopher Hourigan, MD, Dr. C Hourigan, Dr. Christopher Simon Hourigan